Literature DB >> 9305333

Lumboperitoneal shunting for pseudotumor cerebri.

R A Burgett1, V A Purvin, A Kawasaki.   

Abstract

To clarify the appropriate role of lumboperitoneal (LP) shunting in the surgical management of pseudotumor cerebri (PTC), we retrospectively analyzed the clinical data from 30 patients who underwent this procedure. We found LP shunting to be an effective means of acutely lowering intracranial pressure. Symptoms of increased intracranial pressure improved in 82% of patients. Among 14 eyes with impaired visual acuity, 10 (71%) improved by at least two lines. Worsening of vision occurred in only one eye. Of 28 eyes with abnormal Goldmann perimetry, 18 (64%) improved and none worsened. The incidence of serious complications was low. The major drawback of LP shunting was the need for frequent revisions in a few patients. The reason for poor shunt tolerance in certain individuals is unclear. In PTC, LP shunting should be considered as the first surgical procedure for patients with severe visual loss at presentation or with intractable headache (with or without visual loss). After shunting it is important to identify patients who are shunt intolerant.

Entities:  

Mesh:

Year:  1997        PMID: 9305333     DOI: 10.1212/wnl.49.3.734

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  32 in total

1.  Idiopathic Intracranial Hypertension.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-03       Impact factor: 3.598

2.  Lumboperitoneal shunt for idiopathic intracranial hypertension: patients' selection and outcome.

Authors:  Waleed F El-Saadany; Ahmed Farhoud; Ihab Zidan
Journal:  Neurosurg Rev       Date:  2011-09-29       Impact factor: 3.042

Review 3.  Pseudotumor cerebri.

Authors:  Pietro Spennato; Claudio Ruggiero; Raffaele Stefano Parlato; Maria Consiglio Buonocore; Antonio Varone; Emilio Cianciulli; Giuseppe Cinalli
Journal:  Childs Nerv Syst       Date:  2010-08-19       Impact factor: 1.475

4.  Visual Outcomes from Shunting for Idiopathic Intracranial Hypertension.

Authors:  S J Hickman; N Raoof; H Panesar; J M McMullan; I M Pepper; B Sharrack
Journal:  Neuroophthalmology       Date:  2014-11-12

5.  Idiopathic Intracranial Hypertension.

Authors:  Robert K. Shin; Laura J. Balcer
Journal:  Curr Treat Options Neurol       Date:  2002-07       Impact factor: 3.598

Review 6.  Headache attributable to nonvascular intracranial disorders.

Authors:  Mark Obermann; Dagny Holle; Steffen Naegel; Hans-Christoph Diener
Journal:  Curr Pain Headache Rep       Date:  2011-08

7.  Transverse sinus stenting for pseudotumor cerebri: a cost comparison with CSF shunting.

Authors:  R M Ahmed; F Zmudzki; G D Parker; B K Owler; G M Halmagyi
Journal:  AJNR Am J Neuroradiol       Date:  2013-11-28       Impact factor: 3.825

8.  Meta-Analysis of CSF Diversion Procedures and Dural Venous Sinus Stenting in the Setting of Medically Refractory Idiopathic Intracranial Hypertension.

Authors:  S R Satti; L Leishangthem; M I Chaudry
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-06       Impact factor: 3.825

9.  Unilateral transverse sinus stenting of patients with idiopathic intracranial hypertension.

Authors:  M Bussière; R Falero; D Nicolle; A Proulx; V Patel; D Pelz
Journal:  AJNR Am J Neuroradiol       Date:  2009-11-26       Impact factor: 3.825

Review 10.  Headache and the pseudotumor cerebri syndrome.

Authors:  Robert M Mallery; Deborah I Friedman; Grant T Liu
Journal:  Curr Pain Headache Rep       Date:  2014-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.